Recent News

• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.03.2025 - William Blair 45th Annual Growth Stock Conference
• 05.28.2025 - Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
• 05.20.2025 - Veracyte to Participate in Upcoming Investor Conferences
• 05.07.2025 - Veracyte First Quarter 2025 Financial Results Webcast
• 05.07.2025 - Veracyte Announces First Quarter 2025 Financial Results
• 04.25.2025 - Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
• 04.22.2025 - Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
• 04.21.2025 - Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release

Recent Filings

• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2025 - 8-K Current report
• 05.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.07.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.07.2025 - EX-99.1 EX-99.1
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material